Patient Safety Organizations: Voluntary Relinquishment From the Fresenius Medical Care PSO, LLC, 10015 [2017-02623]
Download as PDF
Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices
Agenda items for these meetings are
subject to change as priorities dictate.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–02624 Filed 2–8–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Patient Safety Organizations:
Voluntary Relinquishment From the
Fresenius Medical Care PSO, LLC
Agency for Healthcare Research
and Quality (AHRQ), Department of
Health and Human Services (HHS).
ACTION: Notice of delisting.
AGENCY:
The Patient Safety and
Quality Improvement Act of 2005, 42
U.S.C. 299b–21 to b–26, (Patient Safety
Act) and the related Patient Safety and
Quality Improvement Final Rule, 42
CFR part 3 (Patient Safety Rule),
published in the Federal Register on
November 21, 2008, 73 FR 70732–
70814, establish a framework by which
hospitals, doctors, and other health care
providers may voluntarily report
information to Patient Safety
Organizations (PSOs), on a privileged
and confidential basis, for the
aggregation and analysis of patient
safety events. The Patient Safety Rule
authorizes AHRQ, on behalf of the
Secretary of HHS, to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ by
the Secretary if it is found to no longer
meet the requirements of the Patient
Safety Act and Patient Safety Rule,
when a PSO chooses to voluntarily
relinquish its status as a PSO for any
reason, or when a PSO’s listing expires.
AHRQ has accepted a notification of
voluntary relinquishment from the
Fresenius Medical Care PSO, LLC of its
status as a PSO, and has delisted the
PSO accordingly. The Fresenius
Medical Care PSO, LLC submitted this
request for voluntary relinquishment
after receiving a Notice of Preliminary
Finding of Deficiency.
DATES: The directories for both listed
and delisted PSOs are ongoing and
reviewed weekly by AHRQ. The
delisting was effective at 12:00 Midnight
ET (2400) on January 6, 2017.
ADDRESSES: Both directories can be
accessed electronically at the following
HHS Web site: https://
www.pso.ahrq.gov/listed.
sradovich on DSK3GMQ082PROD with NOTICES
VerDate Sep<11>2014
18:11 Feb 08, 2017
Jkt 241001
Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ,
5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll
free): (866) 403–3697; Telephone (local):
(301) 427–1111; TTY (toll free): (866)
438–7231; TTY (local): (301) 427–1130;
Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
Agency for Healthcare Research and
Quality
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
The Patient Safety Act authorizes the
listing of PSOs, which are entities or
component organizations whose
mission and primary activity are to
conduct activities to improve patient
safety and the quality of health care
delivery.
HHS issued the Patient Safety Rule to
implement the Patient Safety Act.
AHRQ administers the provisions of the
Patient Safety Act and Patient Safety
Rule relating to the listing and operation
of PSOs. The Patient Safety Rule
authorizes AHRQ to list as a PSO an
entity that attests that it meets the
statutory and regulatory requirements
for listing. A PSO can be ‘‘delisted’’ if
it is found to no longer meet the
requirements of the Patient Safety Act
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its
status as a PSO for any reason, or when
a PSO’s listing expires. Section 3.108(d)
of the Patient Safety Rule requires
AHRQ to provide public notice when it
removes an organization from the list of
federally approved PSOs.
AHRQ has accepted a notification
from the Fresenius Medical Care PSO,
LLC, a component entity of Fresenius
Medical Holdings, Inc., PSO number
P0081, to voluntarily relinquish its
status as a PSO. Accordingly, the
Fresenius Medical Care PSO, LLC was
delisted effective at 12:00 Midnight ET
(2400) on January 6, 2017. AHRQ notes
that the Fresenius Medical Care PSO,
LLC submitted this request for voluntary
relinquishment following receipt of the
Notice of Preliminary Finding of
Deficiency sent to the PSO on December
12, 2016.
Fresenius Medical Care PSO, LLC has
patient safety work product (PSWP) in
its possession. The PSO will meet the
requirements of section 3.108(c)(2)(i) of
the Patient Safety Rule regarding
notification to providers that have
reported to the PSO. In addition,
according to sections 3.108(c)(2)(ii) and
3.108(b)(3) of the Patient Safety Rule
regarding disposition of PSWP, the PSO
has 90 days from the effective date of
delisting and revocation to complete the
disposition of PSWP that is currently in
the PSO’s possession.
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
10015
More information on PSOs can be
obtained through AHRQ’s PSO Web site
at https://www.pso.ahrq.gov.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–02623 Filed 2–8–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Scientific Information Request on
Treatment-Resistant Depression: A
Narrative and Systematic Review of
Definitions and Methods in Clinical
Research Studies
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for Scientific
Information Submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review of
Treatment-Resistant Depression: A
Narrative and Systematic Review of
Definitions and Methods in Clinical
Research Studies, which is currently
being conducted by the AHRQ’s
Evidence-based Practice Centers (EPC)
Program. Access to published and
unpublished pertinent scientific
information will improve the quality of
this review. AHRQ is conducting this
systematic review pursuant to Section
902(a) of the Public Health Service Act,
42 U.S.C. 299a(a).
DATES: Submission Deadline on or
before March 13, 2017.
ADDRESSES: Email submissions:
SEADS@epc-src.org.
Print submissions:
Mailing Address: Portland VA
Research Foundation, Scientific
Resource Center, ATTN: Scientific
Information Packet Coordinator, P.O.
Box 69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.):
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, 3710 SW U.S. Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Ryan McKenna, Telephone: 503–220–
8262 ext. 51723 or Email: SIPS@epcsrc.org.
SUMMARY:
The
Agency for Healthcare Research and
Quality has commissioned the
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09FEN1.SGM
09FEN1
Agencies
[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Page 10015]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02623]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Patient Safety Organizations: Voluntary Relinquishment From the
Fresenius Medical Care PSO, LLC
AGENCY: Agency for Healthcare Research and Quality (AHRQ), Department
of Health and Human Services (HHS).
ACTION: Notice of delisting.
-----------------------------------------------------------------------
SUMMARY: The Patient Safety and Quality Improvement Act of 2005, 42
U.S.C. 299b-21 to b-26, (Patient Safety Act) and the related Patient
Safety and Quality Improvement Final Rule, 42 CFR part 3 (Patient
Safety Rule), published in the Federal Register on November 21, 2008,
73 FR 70732-70814, establish a framework by which hospitals, doctors,
and other health care providers may voluntarily report information to
Patient Safety Organizations (PSOs), on a privileged and confidential
basis, for the aggregation and analysis of patient safety events. The
Patient Safety Rule authorizes AHRQ, on behalf of the Secretary of HHS,
to list as a PSO an entity that attests that it meets the statutory and
regulatory requirements for listing. A PSO can be ``delisted'' by the
Secretary if it is found to no longer meet the requirements of the
Patient Safety Act and Patient Safety Rule, when a PSO chooses to
voluntarily relinquish its status as a PSO for any reason, or when a
PSO's listing expires. AHRQ has accepted a notification of voluntary
relinquishment from the Fresenius Medical Care PSO, LLC of its status
as a PSO, and has delisted the PSO accordingly. The Fresenius Medical
Care PSO, LLC submitted this request for voluntary relinquishment after
receiving a Notice of Preliminary Finding of Deficiency.
DATES: The directories for both listed and delisted PSOs are ongoing
and reviewed weekly by AHRQ. The delisting was effective at 12:00
Midnight ET (2400) on January 6, 2017.
ADDRESSES: Both directories can be accessed electronically at the
following HHS Web site: https://www.pso.ahrq.gov/listed.
FOR FURTHER INFORMATION CONTACT: Eileen Hogan, Center for Quality
Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, Room 06N94B,
Rockville, MD 20857; Telephone (toll free): (866) 403-3697; Telephone
(local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY (local):
(301) 427-1130; Email: pso@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety Act authorizes the listing of PSOs, which are
entities or component organizations whose mission and primary activity
are to conduct activities to improve patient safety and the quality of
health care delivery.
HHS issued the Patient Safety Rule to implement the Patient Safety
Act. AHRQ administers the provisions of the Patient Safety Act and
Patient Safety Rule relating to the listing and operation of PSOs. The
Patient Safety Rule authorizes AHRQ to list as a PSO an entity that
attests that it meets the statutory and regulatory requirements for
listing. A PSO can be ``delisted'' if it is found to no longer meet the
requirements of the Patient Safety Act and Patient Safety Rule, when a
PSO chooses to voluntarily relinquish its status as a PSO for any
reason, or when a PSO's listing expires. Section 3.108(d) of the
Patient Safety Rule requires AHRQ to provide public notice when it
removes an organization from the list of federally approved PSOs.
AHRQ has accepted a notification from the Fresenius Medical Care
PSO, LLC, a component entity of Fresenius Medical Holdings, Inc., PSO
number P0081, to voluntarily relinquish its status as a PSO.
Accordingly, the Fresenius Medical Care PSO, LLC was delisted effective
at 12:00 Midnight ET (2400) on January 6, 2017. AHRQ notes that the
Fresenius Medical Care PSO, LLC submitted this request for voluntary
relinquishment following receipt of the Notice of Preliminary Finding
of Deficiency sent to the PSO on December 12, 2016.
Fresenius Medical Care PSO, LLC has patient safety work product
(PSWP) in its possession. The PSO will meet the requirements of section
3.108(c)(2)(i) of the Patient Safety Rule regarding notification to
providers that have reported to the PSO. In addition, according to
sections 3.108(c)(2)(ii) and 3.108(b)(3) of the Patient Safety Rule
regarding disposition of PSWP, the PSO has 90 days from the effective
date of delisting and revocation to complete the disposition of PSWP
that is currently in the PSO's possession.
More information on PSOs can be obtained through AHRQ's PSO Web
site at https://www.pso.ahrq.gov.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-02623 Filed 2-8-17; 8:45 am]
BILLING CODE 4160-90-P